Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...

CAMC Urology recently performed his 100th robotic high intensity focused ultrasound (HIFU) procedure, an advanced treatment for patients with prostate cancer.

DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today unveils at ECR 2026 the industry's most comprehensive portfolio of ...

The average age of men who get diagnosed is 67.

The company's platform integrates genomic sequencing, clinical data analytics, and AI-driven insights across oncology, cardiology, and neuropsychiatry. Tempus serves more than 50% of U.S. oncologists ...

When a doctor suspects bladder cancer, they will order a series of tests which may include urine tests (urinalysis or urine ...

EDAP to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026Company to host conference call and webcast on Wednesday, ...

RadNet (NASDAQ:RDNT) executives highlighted record fourth-quarter results and outlined plans to accelerate growth in 2026, ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, ...

Adjusted EBITDA -- $87.7 million, an increase of 16.9%, achieving a quarterly record. Digital Health adjusted EBITDA -- $4.9 ...

DeepHealth is a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and serves as the umbrella brand for RadNet’s Digital ...